NCT05031325View on ClinicalTrials.gov

Efficacy of a Hemostatic Agent (PuraStat®) in Reducing Delayed Bleeding After Endoscopic Submucosal Dissection

NARecruitingINTERVENTIONAL

Enrollment

288

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

February 28, 2022

Study Completion Date

December 26, 2024

Conditions

Colo-rectal Cancer

Interventions

DEVICE

Endoscopic submucosal dissection with Purastat

Purastat (peptidic gel) application

Trial Locations (1)

Unknown

RECRUITING

Hopital Edouard Herriot, Lyon

All Listed Sponsors

lead

Mathieu Pioche

OTHER